Toyl transferase (CPT) Ib and II (Figures 5d e), and UCPMitochondrial SwellingTo determine the effects of LOS in rats given TNF, MPTP opening was induced against a 50 mM calcium challenge. When mitochondria are exposed to 50 mM calcium concentrations, especially when accompanied by oxidative stress, they undergo massive swelling. As demonstrated in Figures 3b and 3c, the extent of the swelling was higher in 50 mM Ca++ loaded mitochondria obtained from rats in the TNF group. The MPTP opened at a faster rate 1676428 in the presence of Ca++ in rats given TNF than in theFigure 2. Effects of losartan treatment on mRNA expression of gene expression levels for a) TNF, b) iNOS, c) eNOS, d) AT-1R, and e) gp91phox as determined by real-time RT-PCR and protein expression levels of TNF, iNOS, and eNOS were measured by western blotting (Fig. 
2f). Administration of TNF to rats induced significant increases in expression of proinflammatory and oxidative stress genes. Losartan attenuated these increases, thereby suggesting that TNF interacts with ANGII to cause some of its effects. * p,0.05 vs. control; p,0.05 vs.TNF. doi:10.1371/journal.pone.0046568.gTNF, ANG II, and Mitochondrial MedChemExpress 256373-96-3 DysfunctionFigure 3. Representative electron micrographs of isolated rat heart mitochondria from each experimental group. a) Heart mitochondria from the TNF group demonstrated loss of outer and inner membrane structure, disordered cristae, and vacuolization. Note that the heart mitochondria from losartan-treated rats had a normal appearance. b) In the absence of and c) in the presence of a 50 mM calcium challenge. Heart mitochondria from rats given TNF demonstrated more swelling, which was indicative of disordered permeability transition. doi:10.1371/journal.pone.0046568.g(Figure 5f) in TNF +LOS treated rats compared with TNF treated rats. These results further suggest that the interaction of TNF and ANG II induces cardiac mitochondrial oxidative damage, leading to depletion of mitochondrial genes, which in turn impairs mitochondrial respiratory complexes; consequently contributing to cardiac damage in TNF treated rats.was lower; in LOS-treated rats, ATP production rates and ATP/ ADP ratios were normalized (Figures 6d e). These results indicate that TNF negatively affects the mitochondrial electron transport chain and that treatment with the AT-1R antagonist, LOS, can prevent some of these TNF-induced effects. These data further support the assertion that TNF interacts with ANGII to cause mitochondrial damage in this animal model.Mitochondrial Complex StudiesIn order to further assess mitochondrial function, we measured the activities of respiratory complexes I, II, and III with electron paramagnetic resonance spectroscopy. Activities of these complexes decreased with TNF administration (Figures 6a?c), thereby confirming that TNF can cause mitochondrial dysfunction. Interestingly, LOS treatment restored mitochondrial complex activity levels to near get LY-2409021 control levels, again suggesting a role for ANGII in the mitochondrial dysfunction that is caused by TNF.DiscussionIn our study, TNF treatment resulted in significant damage to the mitochondrial membrane and was accompanied by increased mitochondrial O2N2 production, decreased in ATP production (less capable of maintaining ATP levels during contraction in the heart mitochondria, (Figure7). This assertion is supported by several observations. Increased superoxide production, induced by TNF interacting with ANGII, contributes to mitochon.Toyl transferase (CPT) Ib and II (Figures 5d e), and UCPMitochondrial SwellingTo determine the effects of LOS in rats given TNF, MPTP opening was induced against a 50 mM calcium challenge. When mitochondria are exposed to 50 mM calcium concentrations, especially when accompanied by oxidative stress, they undergo massive swelling. As demonstrated in Figures 3b and 3c, the extent of the swelling was higher in 50 mM Ca++ loaded mitochondria obtained from rats in the TNF group. The MPTP opened at a faster rate 1676428 in the presence of Ca++ in rats given TNF than in theFigure 2. Effects of losartan treatment on mRNA expression of gene expression levels for a) TNF, b) iNOS, c) eNOS, d) AT-1R, and e) gp91phox as determined by real-time RT-PCR and protein expression levels of TNF, iNOS, and eNOS were measured by western blotting (Fig. 2f). Administration of TNF to rats induced significant increases in expression of proinflammatory and oxidative stress genes. Losartan attenuated these increases, thereby suggesting that TNF interacts with ANGII to 
cause some of its effects. * p,0.05 vs. control; p,0.05 vs.TNF. doi:10.1371/journal.pone.0046568.gTNF, ANG II, and Mitochondrial DysfunctionFigure 3. Representative electron micrographs of isolated rat heart mitochondria from each experimental group. a) Heart mitochondria from the TNF group demonstrated loss of outer and inner membrane structure, disordered cristae, and vacuolization. Note that the heart mitochondria from losartan-treated rats had a normal appearance. b) In the absence of and c) in the presence of a 50 mM calcium challenge. Heart mitochondria from rats given TNF demonstrated more swelling, which was indicative of disordered permeability transition. doi:10.1371/journal.pone.0046568.g(Figure 5f) in TNF +LOS treated rats compared with TNF treated rats. These results further suggest that the interaction of TNF and ANG II induces cardiac mitochondrial oxidative damage, leading to depletion of mitochondrial genes, which in turn impairs mitochondrial respiratory complexes; consequently contributing to cardiac damage in TNF treated rats.was lower; in LOS-treated rats, ATP production rates and ATP/ ADP ratios were normalized (Figures 6d e). These results indicate that TNF negatively affects the mitochondrial electron transport chain and that treatment with the AT-1R antagonist, LOS, can prevent some of these TNF-induced effects. These data further support the assertion that TNF interacts with ANGII to cause mitochondrial damage in this animal model.Mitochondrial Complex StudiesIn order to further assess mitochondrial function, we measured the activities of respiratory complexes I, II, and III with electron paramagnetic resonance spectroscopy. Activities of these complexes decreased with TNF administration (Figures 6a?c), thereby confirming that TNF can cause mitochondrial dysfunction. Interestingly, LOS treatment restored mitochondrial complex activity levels to near control levels, again suggesting a role for ANGII in the mitochondrial dysfunction that is caused by TNF.DiscussionIn our study, TNF treatment resulted in significant damage to the mitochondrial membrane and was accompanied by increased mitochondrial O2N2 production, decreased in ATP production (less capable of maintaining ATP levels during contraction in the heart mitochondria, (Figure7). This assertion is supported by several observations. Increased superoxide production, induced by TNF interacting with ANGII, contributes to mitochon.